TSPAN8 and neoplasm: TSPAN8 knock-down in the HCCLM3-shTSPAN8 group resulted in a significant decrease in tumor size compared to controls, while TSPAN8 over-expression in the SMMC-7721-TSPAN8 group resulted in a significant increase in tumor size (Figure 4; P < 0.05).